These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 6514017)

  • 21. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.
    Airaksinen MM; Svensk H; Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural requirements for uptake into serotoninergic neurones.
    Ross SB; Ask AL
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):270-7. PubMed ID: 7368945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin modulates the dissociation of [3H]imipramine from human platelet recognition sites.
    Wennogle LP; Meyerson LR
    Eur J Pharmacol; 1982 Dec; 86(2):303-7. PubMed ID: 7160439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H]Tryptamine: high affinity binding sites in rat brain.
    Kellar KJ; Cascio CS
    Eur J Pharmacol; 1982 Mar; 78(4):475-8. PubMed ID: 7075681
    [No Abstract]   [Full Text] [Related]  

  • 25. Complex inhibition of [3H]imipramine binding by serotonin and nontricyclic serotonin uptake blockers.
    Sette M; Briley MS; Langer SZ
    J Neurochem; 1983 Mar; 40(3):622-8. PubMed ID: 6827265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.
    Raisman R; Briley MS; Bouchami F; Sechter D; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1982; 77(4):332-5. PubMed ID: 6813892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site.
    Langer SZ; Raisman R; Tahraoui L; Scatton B; Niddam R; Lee CR; Claustre Y
    Eur J Pharmacol; 1984 Feb; 98(1):153-4. PubMed ID: 6325207
    [No Abstract]   [Full Text] [Related]  

  • 28. Binding of [3H]imipramine and [3H]desipramine as biochemical tools for studies in depression.
    Langer SZ; Raisman R
    Neuropharmacology; 1983 Mar; 22(3 Spec No):407-13. PubMed ID: 6304558
    [No Abstract]   [Full Text] [Related]  

  • 29. Tryptamine: a neuromodulator or neurotransmitter in mammalian brain?
    Jones RS
    Prog Neurobiol; 1982; 19(1-2):117-39. PubMed ID: 6131482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.
    Born GV; Juengjaroen K; Michal F
    Br J Pharmacol; 1972 Jan; 44(1):117-39. PubMed ID: 5015032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues.
    Horn AS
    J Neurochem; 1973 Oct; 21(4):883-8. PubMed ID: 4754864
    [No Abstract]   [Full Text] [Related]  

  • 32. Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.
    Segonzac A; Tateishi T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):33-7. PubMed ID: 6514017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets.
    Pletscher A
    Br J Pharmacol Chemother; 1968 Jan; 32(1):1-16. PubMed ID: 4870578
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.